LauraNewYork
Networker
Hi all,
I code EMs for a hematology/oncology practice. In the Risk column of the 2021 MDM is the example of drug therapy requiring intensive monitoring for toxicity. This is a High Risk. A lot of our patients are on chemotherapy and/or immunotherapy drugs many of which are cytotoxic, but I honestly don't know if all of these drugs fit this description.
I'm looking for some input. Should I have my providers include in the documentation that the drug(s) "have a high level of toxicity" or some related wording?
Laura
I code EMs for a hematology/oncology practice. In the Risk column of the 2021 MDM is the example of drug therapy requiring intensive monitoring for toxicity. This is a High Risk. A lot of our patients are on chemotherapy and/or immunotherapy drugs many of which are cytotoxic, but I honestly don't know if all of these drugs fit this description.
I'm looking for some input. Should I have my providers include in the documentation that the drug(s) "have a high level of toxicity" or some related wording?
Laura